@anish_koka @michelaccad @SanjayGill1 @JeremySussman @mikejohansenmd Most "stable" NYHA class II pts with HFrEF will still die of HF or sudden death in 2020. Thankfully, these pts were well-represented in pivotal trials & benefit comparably to those wi
~80% had no med changes? Fallacy of "stable" HF ➡️ reminded in PARADIGM-HF, 20% of pts w/o a prior HF Hosp. experienced a 1⃣-event (HF hosp/CV Death) and for 51% of those pts: death preceded HF hosp. Need to revisit "stable on current regimen" each visit h
Efficacy of Sacubitril/Valsartan Relative to a Prior Decompensation: The PARADIGM-HF Trial. https://t.co/QTtoUp5mxX
RT @JACCJournals: Should Entresto be used in stable patients or those with signs of instability? #JACCHF https://t.co/bje2qIzKLN https://t…
RT @JACCJournals: Should Entresto be used in stable patients or those with signs of instability? #JACCHF https://t.co/bje2qIzKLN https://t…
RT @JACCJournals: Should Entresto be used in stable patients or those with signs of instability? #JACCHF https://t.co/bje2qIzKLN https://t…
RT @hilariobad59: Efficacy of Sacubitril/Valsartan Relative to a Prior Decompensation: The PARADIGM-HF Trial https://t.co/kdNq9SqE08
Efficacy of Sacubitril/Valsartan Relative to a Prior Decompensation: The PARADIGM-HF Trial https://t.co/9Yk1QytbRk via @jaccjournals #IAN
Efficacy of Sacubitril/Valsartan Relative to a Prior Decompensation: The PARADIGM-HF Trial https://t.co/kdNq9SqE08
RT @JACCJournals: Should Entresto be used in stable patients or those with signs of instability? #JACCHF https://t.co/bje2qIzKLN https://t…
RT @JACCJournals: Should Entresto be used in stable patients or those with signs of instability? #JACCHF https://t.co/bje2qIzKLN https://t…
RT @JACCJournals: Should Entresto be used in stable patients or those with signs of instability? #JACCHF https://t.co/bje2qIzKLN https://t…
RT @JACCJournals: Should Entresto be used in stable patients or those with signs of instability? #JACCHF https://t.co/bje2qIzKLN https://t…
Article | JACC: Heart Failure | American College of Cardiology Foundation https://t.co/SHaS11F9Bf #IAN
Should Entresto be used in stable patients or those with signs of instability? #JACCHF https://t.co/bje2qIzKLN https://t.co/8utgCDSxQA